Back

Feasibility and diagnostic yield of a photoplethysmography-based arrhythmia screening and integrated management pathway in a chronic obstructive pulmonary disease outpatient clinic

7 April 2024 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Arrhythmias 3: atrial fibrillation Photoplethysmography EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Miss Maartje Hereijgers

Academic Hospital Maastricht, Maastricht (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Unfolding the transition ratio: insight into the diagnostic criteria for the diagnosis of the origin of outflow tract ventricular arrhythmias.
Doctor L. Lazzari (Terni, IT)
Abstract Slides Video
Presentation thumbnail
Photoplethysmography recordings preceding onset atrial fibrillation show a higher heart rate variability - a TeleCheck-AF subanalysis
Doctor H. Hillmann (Hannover, DE)
Abstract Slides Video
Presentation thumbnail
Impact of Pirfenidone on arrhythmic and clinical outcomes in patients with idiopathic pulmonary fibrosis
Doctor S. Im (Pusan, KR)
Abstract Slides Video
Presentation thumbnail
Diagnostic accuracy of smartwatches for automated atrial fibrillation detection over time: insights from the basel wearable study
Ms C. Isenegger (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Clinical findings and outcomes of Brugada syndrome in women
Mr M. Kruska (Mannheim, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias 3: atrial fibrillation

The Event

Event poster

EHRA 2024

7 April 2024 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Remote heart rhythm assessment using smartphone-based photoplethysmography in primary care to detect undiagnosed atrial fibrillation in patients with chronic obstructive pulmonary disease
thumbnail
Congress Presentation
Proactive atrial fibrillation screening in primary care: assessing the impact of a device-based approach
thumbnail
Congress Presentation
Modern mobile health technologies to screen for atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources